Moderna, Inc. (MRNA) Operating cash flow 2016–2025
Moderna, Inc. (MRNA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$1.9BFY2025 · since FY2016: $66.7M → -$1.9B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$1.9B | +37.6% |
| FY2024 | -$3.0B | +3.7% |
| FY2023 | -$3.1B | -162.6% |
| FY2022 | $5.0B | -63.4% |
| FY2021 | $13.6B | +571.9% |
| FY2020 | $2.0B | +541.6% |
| FY2019 | -$459.0M | -38.7% |
| FY2018 | -$330.9M | +0.2% |
| FY2017 | -$331.5M | -596.7% |
| FY2016 | $66.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice